highli
pathogen
influenza
viru
caus
lethal
multiorgan
diseas
poultri
result
signific
econom
loss
public
health
concern
mani
part
world
greatest
threat
pose
viru
abil
caus
mortal
human
potenti
compromis
food
suppli
possibl
econom
impact
viral
mainten
poultri
potenti
risk
humantohuman
transmiss
emerg
pandem
strain
reassort
effect
safe
poultri
vaccin
elicit
broadli
protect
immun
respons
evolv
flu
strain
would
provid
countermeasur
reduc
likelihood
transmiss
viru
domest
bird
human
simultan
would
protect
commerci
poultri
oper
subsist
farmer
dna
vaccin
shown
elicit
robust
immun
respons
variou
anim
speci
mice
nonhuman
primat
human
trial
vaccin
elicit
cellular
humor
immun
respons
variou
infecti
agent
includ
influenza
sar
siv
hiv
addit
abil
elicit
antibodi
respons
also
stimul
antigenspecif
sustain
cell
respons
dna
vaccin
use
experiment
variou
infecti
agent
varieti
mammal
includ
cattl
infecti
bovin
rhinotracheitisbovin
diarrhea
viru
leptospirosi
mycobacteriosi
pig
classic
swine
fever
viru
mycoplasmosi
hors
west
nile
viru
rabi
addit
dna
vaccin
test
avian
plasmodium
infect
penguin
influenza
infecti
bursal
diseas
chicken
duck
hepat
b
viru
duck
avian
metapneumoviru
chlamydia
psittaci
turkey
review
ref
use
chicken
gener
antisera
specif
influenza
virus
confer
protect
low
pathogen
strain
one
previou
report
monoval
dna
vaccin
effect
match
isol
protect
multival
dna
vaccin
heterolog
strain
report
develop
character
dna
vaccin
modal
use
poultri
offer
potenti
countermeasur
hpai
avian
influenza
outbreak
viru
infect
human
typic
anim
sourc
includ
commerci
wild
avian
speci
livestock
possibl
nondomest
anim
speci
mark
divers
host
rang
type
influenza
virus
mani
expert
specul
pandem
strain
type
influenza
could
evolv
avian
speci
avian
influenza
virus
could
contribut
virul
gene
pandem
strain
reassort
thu
reason
consid
vaccin
poultri
would
stimul
potent
broad
protect
immun
respons
undertak
effort
import
differenti
infect
vaccin
anim
anim
protect
permit
monitor
new
infect
use
proven
sensit
methodolog
studi
use
autom
high
capac
needlefre
inject
devic
medic
intern
technolog
inc
denver
co
explor
feasibl
dna
vaccin
poultri
optim
inject
condit
altern
multival
dna
vaccin
regimen
analyz
compar
magnitud
breadth
neutral
antibodi
well
protect
efficaci
challeng
mous
chicken
model
hpai
infect
find
suggest
possibl
develop
multival
dna
vaccin
poultri
protect
multipl
hpai
strain
could
keep
pace
continu
evolut
avian
influenza
virus
evalu
efficaci
multival
dna
vaccin
initi
studi
perform
mice
express
vector
encod
ten
phylogenet
divers
strain
influenza
virus
gener
synthesi
cdna
see
materi
method
plasmid
express
vector
pcmvr
pcmvr
mediat
high
level
express
immunogen
vivo
anim
immun
express
vector
intramuscularli
im
three
week
interv
antisera
evalu
day
third
immun
abil
neutral
hpai
pseudotyp
lentivir
vector
previous
describ
previous
shown
lentivir
assay
inhibit
lai
yield
similar
result
microneutr
hai
analys
higher
sensit
mice
signific
neutral
antibodi
gener
homolog
detect
consist
lai
except
cross
reactiv
standard
isol
variabl
exampl
titer
exceed
observ
ahong
lesser
respons
detect
strain
fig
heterolog
neutral
variabl
fulli
correl
degre
related
specif
ha
abil
immunogen
gener
robust
crossreact
antibodi
consist
previou
observ
determin
whether
immun
multipl
simultan
could
expand
breadth
neutral
antibodi
respons
without
signific
loss
magnitud
combin
ha
dna
vaccin
immunogen
administ
im
proport
lower
concentr
per
immunogen
group
mice
see
materi
method
remark
despit
log
lower
dna
concentr
compon
signific
neutral
antibodi
titer
gener
immunogen
neutral
ha
pseudovirus
dilut
fig
evalu
whether
similar
breadth
immun
could
gener
fewer
immunogen
two
differ
combin
immunogen
select
base
phylogenet
divers
ha
among
avian
influenza
virus
crossreact
neutral
antibodi
respons
select
individu
immunogen
fig
expect
substanti
differ
breadth
neutral
two
set
immunogen
multival
vaccin
fig
b
vs
c
one
set
neutral
homolog
strain
compar
monoval
immunogen
multival
immun
respons
fewer
crossreact
antibodi
detect
direct
promin
aegypt
fig
ha
set
contrast
set
elicit
consist
compar
neutral
homolog
heterolog
virus
titer
exceed
test
ha
strain
fig
ha
set
observ
compon
multival
dna
vaccin
therefor
possibl
use
multival
dna
immun
select
base
neutral
antibodi
breadth
phylogenet
relationship
reduc
number
compon
vaccin
maintain
substanti
breadth
cross
neutral
mice
immun
describ
challeng
heterolog
viru
week
final
dna
vaccin
anim
challeng
highli
pathogen
viru
intranas
morbid
mortal
monitor
day
viral
challeng
control
anim
inject
plasmid
express
vector
insert
die
within
day
infect
complet
surviv
observ
group
immun
compon
set
compon
multival
dna
vaccin
fig
immun
ha
deriv
strain
set
compon
multival
dna
vaccin
show
surviv
rate
approach
contrast
anim
inject
ha
plasmid
dna
deriv
diverg
show
lower
percent
surviv
lethal
viral
challeng
surviv
differ
group
assess
use
logrank
test
gehanwilcoxon
test
surviv
curv
pair
group
test
deem
signific
pvalu
mice
inject
im
differ
ha
set
ha
set
show
signific
differ
compar
control
p
valu
among
haimmun
group
signific
differ
two
group
p
comparison
exampl
signific
differ
observ
group
least
surviv
among
ha
immun
group
ha
group
p
ha
p
ha
set
p
ha
set
p
therefor
exclud
possibl
death
group
may
due
random
chanc
sinc
desir
confer
protect
immun
poultri
ha
dna
vaccin
effect
mice
next
examin
breadth
potenc
singl
multipl
ha
plasmid
immun
chicken
abil
chicken
gener
specif
antibodi
assess
three
strain
show
broad
cross
protect
mous
studi
administ
individu
combin
differ
inject
method
addit
needl
inject
needlefre
repetit
inject
devic
medic
intern
technolog
inc
denver
co
analyz
devic
dispers
ml
inject
dose
dermal
subcutan
intramuscular
tissu
depend
upon
pressur
adjust
power
ga
pressur
plunger
inject
condit
determin
histolog
analysi
tissu
receiv
inject
india
ink
pressur
psi
chosen
sinc
enabl
consist
deliveri
intraderm
subcutan
tissu
fig
immun
chicken
control
plasmid
cmvr
without
ha
gene
insert
elicit
minim
neutral
antibodi
titer
compar
haimmun
anim
week
dna
immun
nearli
chicken
immun
either
monoval
multival
ha
dna
vaccin
gener
signific
neutral
titer
fig
tabl
gener
progress
increas
amount
neutral
success
dna
vaccin
data
shown
maxim
respons
week
dna
immun
highest
consist
level
trival
vaccin
group
deliv
devic
neutral
indonesia
ha
strain
robust
neutral
near
titer
greater
monoval
multival
vaccin
elicit
robust
homolog
fig
heterolog
ha
neutral
fig
similar
respons
note
group
includ
administr
monoval
subcutan
needl
syring
via
fig
second
row
neutral
respons
chicken
immun
monoval
indonesia
similar
trival
vaccin
fig
even
though
one
chicken
multival
vaccin
group
produc
almost
degre
neutral
time
point
protect
produc
high
neutral
antibodi
titer
reason
uncertain
possibl
relat
nonspecif
inhibitor
sera
determin
whether
chicken
immun
singl
multipl
dna
vaccin
protect
lethal
challeng
heterolog
hpai
viru
vaccin
chicken
inocul
highli
pathogen
heterolog
viru
intranas
use
standard
method
monitor
morbid
mortal
viral
shed
serum
antibodi
control
anim
die
within
day
infect
surviv
note
rest
chicken
fig
anim
healthi
show
sign
clinic
diseas
malais
euthan
day
evid
viral
shed
monitor
via
tracheal
cloacal
swab
infect
chicken
day
challeng
determin
embryon
inocul
data
shown
egg
infecti
dose
limit
detect
viru
particl
compar
rel
efficaci
dna
vaccin
deliv
im
needl
syring
versu
needlefre
devic
inject
doserespons
studi
perform
amount
dna
vaccin
rang
two
inocul
experi
ha
deriv
substitut
sinc
repres
contemporari
isol
observ
rate
protect
higher
among
anim
receiv
agrojet
im
inject
fig
b
vs
c
mode
provid
complet
protect
anim
dose
higher
protect
anim
receiv
dose
fig
c
surviv
differ
consecut
dose
assess
use
logrank
test
surviv
curv
pair
group
test
deem
signific
pvalu
margin
signific
pvalu
chicken
inject
im
show
margin
signific
differ
p
group
signific
differ
control
p
comparison
differ
control
margin
signific
p
chicken
inject
use
show
signific
differ
p
control
p
comparison
differ
control
lastli
surviv
differ
im
dose
group
signific
neutral
antibodi
respons
homolog
heterolog
correspond
protect
correl
dose
higher
titer
elicit
inject
compar
needl
tabl
assess
viabl
viral
shed
inocul
chick
embryo
inocul
three
day
viru
challeng
week
note
embryon
lethal
dose
embryon
lethal
group
data
shown
sinc
hpai
viru
first
appear
ten
year
ago
highli
pathogen
avian
influenza
viru
shown
increas
diversif
dissemin
asia
africa
europ
addit
effect
human
health
crossspeci
transmiss
abil
compromis
food
sourc
pose
continu
threat
public
health
evolv
adapt
differ
speci
pandem
potenti
viru
especi
relat
poultri
industri
reservoir
avian
host
underscor
need
vaccin
offer
broad
spectrum
immun
protect
lethal
viral
challeng
viru
remain
restrict
abil
infect
human
undergo
effici
humantohuman
transmiss
persist
spread
poultri
increas
risk
emerg
pandem
strain
one
approach
pandem
risk
reduct
limit
propag
viru
poultri
relev
avian
speci
previous
report
dna
vaccin
encod
ha
confer
protect
highli
lethal
human
pandem
influenza
viru
viru
mice
dna
vaccin
offer
sever
advantag
includ
abil
express
divers
antigen
toler
variou
host
eas
deliveri
stabil
storag
distribut
without
necess
maintain
cold
chain
shown
safe
efficaci
varieti
anim
model
contain
viral
protein
use
screen
infect
also
address
need
differenti
vaccin
infect
anim
evid
dna
vaccin
elicit
cellmedi
immun
influenza
ha
addit
induc
antibodi
respons
effect
could
significantli
contribut
protect
immun
virus
show
genet
drift
reduc
suscept
neutral
ideal
highli
effect
influenza
vaccin
abl
let
host
develop
protect
immun
respons
match
live
viru
challeng
also
elicit
robust
protect
immun
respons
broad
rang
homolog
heterolog
influenza
strain
multival
vaccin
contain
divers
serotyp
could
expand
antigen
breadth
suffici
provid
protect
heterolog
challeng
may
preclud
emerg
vaccineresist
strain
may
aris
due
evolutionari
vaccin
pressur
viru
due
antigen
drift
shift
influenza
viru
genom
difficult
predict
next
domin
strain
avian
endem
outbreak
dna
vaccin
synthes
rel
short
period
time
target
mutat
tailor
specif
viral
serotyp
mutat
promot
focus
enhanc
immun
respons
may
particularli
import
event
outbreak
specif
key
epidem
control
use
modifi
codon
ensur
maxim
express
host
elimin
possibl
recombin
influenza
virus
might
potenti
gener
new
strain
broadli
protect
murin
vaccin
develop
includ
vari
strain
multival
vaccin
fig
howev
less
practic
includ
larg
number
differ
one
vaccin
due
cost
complex
manufactur
vaccin
therefor
simplifi
vaccin
regimen
base
crossneutr
studi
phylogenet
relationship
trival
vaccin
subsequ
identifi
studi
due
avail
anim
challeng
studi
compon
ha
includ
ha
test
vaccin
candid
challeng
studi
trival
dna
ha
vaccin
includ
includ
repres
broad
rang
influenza
strain
ha
sequenc
analysi
three
dna
immun
use
initi
demonstr
protect
immun
use
previous
elicit
protect
mice
found
effect
protect
immun
could
induc
two
dna
vaccin
littl
trival
dna
immun
use
idsc
rout
devic
addit
base
chick
embryo
inocul
data
believ
effect
neutral
viru
lack
infecti
viral
shed
chicken
vaccin
littl
dna
devic
capac
rapid
repetit
inject
lower
quantiti
stabil
dna
enhanc
practic
util
approach
vaccin
endang
speci
captiv
administr
poultri
anim
obtain
repositori
center
diseas
control
prevent
cdc
atlanta
georgia
viru
propag
old
embryon
chicken
egg
store
use
viru
titrat
reed
muench
method
determin
plasmid
encod
differ
version
ha
protein
clade
genbank
clade
genbank
ahong
clade
genbank
ahong
genbank
clade
clade
genbank
clade
clade
genbank
clade
genbank
clade
genbank
clade
genbank
clade
genbank
synthes
use
humanpref
codon
geneart
regensburg
germani
ha
cdna
divers
strain
influenza
virus
insert
plasmid
express
vector
pcmvr
pcmvr
mediat
high
level
express
immunogen
vivo
initi
trival
immun
chicken
strain
use
dose
respons
studi
vietnam
strain
replac
immunogen
use
dna
vaccin
contain
cleavag
site
mutat
pqrerrrkkrg
pqretrg
previous
describ
mutat
gener
sitedirect
mutagenesi
use
quickchang
kit
stratagen
la
jolla
ca
week
old
femal
balbc
mice
purchas
jackson
laboratori
maintain
aaalacaccredit
vaccin
research
center
anim
care
facil
bethesda
md
specif
pathogenfre
condit
experi
approv
vaccin
research
center
anim
care
use
committe
mice
immun
previous
describ
briefli
mice
anim
test
group
anim
neg
control
group
immun
three
time
total
plasmid
dna
pb
ph
im
week
singl
plasmid
group
dna
plasmid
volum
administ
anim
pcmvr
pcmvr
pcmvr
pcmvr
pcmvr
ahong
pcmvr
ahong
pcmvr
pcmvr
pcmvr
pcmvr
pcmvr
plasmid
combin
group
ha
receiv
dna
ha
plasmid
total
use
singl
plasmid
group
mention
two
plasmid
combin
group
ha
ha
set
plasmid
dna
use
total
dna
remain
ha
set
group
contain
pcmvr
ahong
pcmvr
pcmvr
pcmvr
pcmvr
ha
set
group
contain
pcmvr
pcmvr
pcmvr
pcmvr
ahong
pcmvr
serum
collect
day
last
vaccin
studi
carri
aaalacaccredit
anim
facil
univers
maryland
school
medicin
six
group
onedayold
male
femal
spafa
white
leghorn
chicken
gallu
domesticu
obtain
charl
river
laboratori
connecticut
anim
hous
brooder
grower
cage
mcmurray
hatcheri
iowa
feed
teklad
japanes
quail
diet
harlanteklad
wi
water
provid
anim
ad
libitum
studi
perform
strict
accord
guid
approv
anim
care
use
committe
vaccin
research
center
nih
univers
maryland
dna
immun
perform
describ
week
total
dose
one
combin
follow
dna
plasmid
volum
administ
anim
pcmvr
pcmvrha
pcmvrha
pcmvrha
group
receiv
intradermalsubcutan
immun
via
pcmvr
pcmvrha
pcmvrha
plu
pcmvrha
plu
pcmvrha
pcmvrha
respect
group
receiv
subcutan
immun
via
needl
syring
pcmvrha
group
receiv
intramuscular
immun
via
needl
syring
pcmvrha
blood
sampl
collect
alar
vein
chicken
variou
interv
group
challeng
week
intranas
virus
viru
load
studi
cloacal
tracheal
swab
collect
anim
day
post
challeng
titrat
viru
infect
embryon
egg
chicken
monitor
day
sign
diseas
death
surviv
chicken
underw
necropsi
day
post
challeng
dose
respons
experi
five
group
immun
trival
ha
vaccin
pcmvrha
pcmvrha
pcmvrha
use
three
plasmid
plasmid
plasmid
plasmid
control
vector
administ
im
needl
syring
addit
five
group
inject
plasmid
dose
use
inject
devic
needlefre
devic
use
mass
deliveri
vaccin
drug
livestock
poultri
devic
semiautomat
requir
small
tank
compress
air
low
pressur
deliveri
upon
trigger
activ
dispers
inject
precis
dose
muscl
dermi
subcutan
tissu
depend
set
standard
use
use
effect
volum
ml
inject
studi
abl
effect
deliv
ml
inject
anim
dermissubcutan
tissu
pressur
psi
sixtyeight
week
last
immun
femal
balbc
mice
lightli
anesthet
ketaminexylazin
inocul
intranas
viru
dilut
phosphatebuff
salin
ul
volum
mice
monitor
daili
morbid
measur
weight
loss
mortal
day
post
infect
mous
lost
bodi
weight
euthan
experi
involv
hpai
viru
conduct
aaalac
accredit
facil
bioqual
inc
gaithersburg
md
bsl
condit
includ
enhanc
requir
usda
select
agent
program
white
leghorn
chicken
challeng
one
week
last
immun
lethal
dose
influenza
viru
equival
base
previou
challeng
chicken
infect
viru
intranas
tracheal
cloacal
swab
collect
day
postchalleng
store
glass
vial
contain
bhi
medium
brain
heart
infus
becton
dickinson
blood
collect
day
postchalleng
serum
titer
microneutr
assay
chicken
observ
score
daili
clinic
sign
infect
morbid
mortal
chicken
surviv
studi
bled
human
euthan
day
postchalleng
lung
heart
intestin
kidney
collect
sampl
store
formalin
histopatholog
experi
carri
condit
investig
wear
appropri
protect
equip
compliant
institut
anim
care
use
committeeapprov
protocol
anim
welfar
act
regul
univers
maryland
colleg
park
maryland
repres
tracheal
cloacal
swab
chosen
run
assay
comparison
viru
titer
determin
method
reed
meunch
briefli
swab
use
infect
dayold
embryon
chicken
egg
dilut
three
egg
inocul
per
dilut
incub
hour
titrat
neutral
antibodi
titrat
serum
sampl
collect
week
postvaccin
day
postchalleng
microneutr
assay
perform
use
plate
format
serum
treat
receptordestroy
enzym
denka
seiken
co
treat
per
manufactur
instruct
overnight
incub
subsequ
inactiv
sampl
brought
final
dilut
use
pb
sampl
serial
dilut
viru
dilut
ad
well
plate
incub
hour
follow
incub
supernat
use
infect
second
plate
mdck
cell
micropl
incub
minut
minut
supernat
serum
viru
discard
optimem
contain
antibioticsantimycot
tpcktrypsin
ad
incub
day
day
supernat
well
transfer
new
micropl
ha
assay
perform
calcul
antibodi
titer
viru
cell
control
includ
assay
twofold
dilut
heatinactiv
sera
test
microneutr
assay
previous
describ
presenc
antibodi
neutral
infect
tissu
cultur
infecti
dose
viru
mdck
cell
monolay
use
two
well
per
dilut
plate
recombin
lentivir
vector
express
luciferas
report
gene
produc
previous
describ
neutral
assay
antisera
immun
anim
heatinactiv
minut
mix
pseudoviru
variou
dilut
seraviru
mixtur
ad
cell
b
w
tc
isopl
wallac
turku
finland
cellswel
two
hour
later
plate
wash
fresh
medium
ad
cell
lyse
mammalian
cell
lysi
buffer
promega
madison
wi
hr
infect
luciferas
activ
measur
use
luciferas
assay
system
promega
madison
wi
follow
strain
use
product
pseudotyp
virus
ha
use
ahong
ahong
na
use
hahi
titer
determin
previous
describ
briefli
ha
titer
calcul
use
chicken
red
blood
cell
suspens
pb
ad
twofold
dilut
viru
pb
mix
incub
room
temperatur
minut
ha
titer
calcul
reciproc
valu
highest
dilut
caus
complet
hemagglutin
hi
titer
calcul
titrat
antiserum
treat
receptordestroy
enzym
equival
amount
viru
four
hemagglutin
dose
ad
well
well
incub
room
temperatur
minut
suspens
chicken
red
blood
cell
ad
hi
titer
calcul
minut
reciproc
serum
dilut
inhibit
hemagglutin
